Know your world in 60 words - Read News in just 1 minute
Hot Topics
Select the content to hear the Audio

Added on : 2021-01-16 15:37:46

The Resident Doctors' Association (RDA) of the Ram Manohar Lohia Hospital here on Saturday requested the medical superintendent to vaccinate them with Oxford Covid-19 vaccine Covishield. In a letter to the medical superintendent, the association said the resident doctors were "a bit apprehensive" about Covaxin and might not participate in the immunisation drive in large numbers thus defeating the purpose of the exercise which began in the country on Saturday.

"We have come to know that the Covid-19 vaccination drive is being conducted by the hospital today. Covaxin manufactured by Bharat Biotech is being preferred in our hospital over Covishield manufactured by Serum Institute. "The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination. We request you to vaccinate us with Covishield which has completed all stages of trial before its roll-out," the letter stated.

The Resident Doctors' Association (RDA) of the Ram Manohar Lohia Hospital here on Saturday requested the medical superintendent to vaccinate them with Oxford Covid-19 vaccine Covishield. In a letter to the medical superintendent, the association said the resident doctors were "a bit apprehensive" about Covaxin and might not participate in the immunisation drive in large numbers thus defeating the purpose of the exercise which began in the country on Saturday.

"We have come to know that the Covid-19 vaccination drive is being conducted by the hospital today. Covaxin manufactured by Bharat Biotech is being preferred in our hospital over Covishield manufactured by Serum Institute. "The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination. We request you to vaccinate us with Covishield which has completed all stages of trial before its roll-out," the letter stated.

Editor & Publisher : Dr Dhimant Purohit

Headlines

Good News

politics

India

World